Acadian Asset Management
TRML

Acadian Asset Management’s Tourmaline Bio TRML Stock Holding History

Acadian Asset Management’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,122
Closed -$34K – 1846
2023
Q2 		$34K Sell
1,122
-22,729
-95% -$580K ﹤0.01% 1575
2023
Q1 		$447K Buy
23,851
+12,710
+114% +$210K ﹤0.01% 1076
2022
Q4 		$113K Buy
11,141
+7,076
+174% +$114K ﹤0.01% 1408
2022
Q3 		$106K Buy
+4,065
New +$148K ﹤0.01% 1350

Other funds holding TRML

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Acadian Asset Management's TRML Position: Q3 2023 in Review

Acadian Asset Management sold out of Tourmaline Bio (TRML) in Q3 2023, closing a stake of 1,122 shares — an estimated $34K sold.

Acadian Asset Management first reported a position in TRML in Q3 2022 and held it in 4 quarters. The position peaked at $447K in Q1 2023. 48 funds tracked by Wall St. Rank hold TRML as of Q3 2023.

  • Acadian Asset Management reported no remaining Tourmaline Bio position as of Q3 2023 after selling out during the quarter.
  • Acadian Asset Management sold 1,122 Tourmaline Bio shares in Q3 2023, an estimated $34K.
  • Acadian Asset Management first reported a position in Tourmaline Bio in Q3 2022 and held it in 4 quarters.
  • Acadian Asset Management's Tourmaline Bio position peaked at $447K in Q1 2023.
  • 48 funds tracked by Wall St. Rank held Tourmaline Bio as of Q3 2023.

Based on Acadian Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.